Search

everythinglearnresearchcommunity

for

Search:↓

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Somatic BHD mutations are rare in Japanese renal tumors.

Vitamin D receptor helps prevent skin tumors.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

DFMO may help control hair growth and treat cancer.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Blocking IL-8 can reduce skin rashes from cancer treatment.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Tofacitinib is effective and safe for treating severe alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Ritlecitinib works well and is safe for treating alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.